On average, people are living longer than before, raising a broader conversation about how to create an ecosystem that effectively combines the delivery of care with proven ways to prevent illness.

See www.mckinsey.com/privacy-policy for privacy information

Global spending on climate adaptation is running at roughly a third of what protecting everyone exposed today would require. At 2°C of warming, the gap widens further still. The economic case for closing it is strong, and yet investment remains far short of what the science demands

In this episode, host Debbi Cheong speaks with Mekala Krishnan, co-author of McKinsey Global Institute’s Advancing Adaptation report, and Yuito Yamada, Senior Partner at McKinsey. Together they examine where the adaptation gap is largest, why heat and drought account for more than three quarters of spending needs, and how Asia sits at the centre of the challenge.

The return on adaptation investment is clear: the spend on resilience today returns roughly three times its cost in avoided damage, rising to seven as hazards worsen. The long-term value is clear, so what will it take to translate that case into action at the scale the problem demands?

Read the report on the McKinsey Global Institute website here: https://www.mckinsey.com/mgi/our-research/advancing-adaptation-mapping-costs-from-cooling-to-coastal-defenses

See www.mckinsey.com/privacy-policy for privacy information

Foreign direct investment is increasingly being channeled into future-shaping industries, reconfiguring trade networks.

In this Future of Asia Podcast episode, host Debbi Cheong talks to McKinsey experts Jeongmin Seong and Tiago Devesa, two of the authors of the McKinsey Global Institute (MGI) report, The FDI shake-up: How foreign direct investment today may shape industry and trade tomorrow, about the impact of new FDI announcements globally. They focus on Asia, which accounts for about 50 percent of global trade flows, and its central role in the new configurations of trade.

See www.mckinsey.com/privacy-policy for privacy information

Governments and health systems across Asia aspire to shift toward proactive, preventive care. Yet historically, prevention budgets and policies haven’t matched the rhetoric, leaving reactive treatment models dominant.

Today, a new era of change is emerging — from public health initiatives and infrastructure planning to pharmaceutical and wearable-driven innovation — signaling that prevention and treatment are on track to converge for better outcomes. Can Asia become the first region to truly integrate prevention and innovation at scale?

In this episode, host Debbi Cheong is joined by Hemant Ahlawat, Senior Partner at McKinsey & Company in Zurich, and Panco Georgiev, Senior Partner in Dubai.

See www.mckinsey.com/privacy-policy for privacy information

Narayana Murthy, founder of Indian technology services and consulting giant, Infosys, discusses the vital role that respect and compassion play for him in being a successful business lead

See www.mckinsey.com/privacy-policy for privacy information

Frontier technologies present exciting possibilities for organizations, but their full potential needs to be unlocked. The challenge? Turning cutting-edge breakthroughs like agentic AI, advanced semiconductors, and robotics into real business impact while managing talent gaps, organizational change, and the complexities of rapid technological advancement.

In this episode of the McKinsey Future of Asia Podcast, host Debbi Cheong is joined by Lareina Yee (Senior Partner, McKinsey & Company), Michael Chui (Senior Fellow, QuantumBlack, a McKinsey company), and Vinayak HV (Senior Partner, McKinsey & Company). They explore how Asia's unique energy landscape, demographics, and innovation ecosystems are positioning the region as a global leader in technology adoption and transformation.

See www.mckinsey.com/privacy-policy for privacy information

Biotech entrepreneurs across Asia are navigating funding gaps, weak innovation ecosystems, and unpredictable regulatory systems. For many, these challenges make it difficult to scale science-led businesses and deliver affordable healthcare solutions.

In this episode, host Gautam Kumra, Chairman of McKinsey Asia, sits down with Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group. They discuss how she overcame a lack of funding, limited infrastructure, and regulatory hurdles to build one of Asia’s first and most successful biotech companies — pioneering affordable biosimilars, shaping biotech policy in India, and scaling purpose-driven innovation from the ground up.

The episode also features McKinsey partner Cheryl SH Lim, and Director of Learning, CEO Institute, Jennifer Chiang.

See www.mckinsey.com/privacy-policy for privacy information

Indonesia has set an ambition to become a high-income economy by 2045. Is this possible? Two McKinsey experts discuss how it could be and what actions would need to be taken to achieve it.

See www.mckinsey.com/privacy-policy for privacy information